MD SB124

Prohibits sale in Maryland of gene structure- or function-modifying products unless properly labeled, with "modern biotechnology methods" defined to include gene editing, RNA interference, and transgenesis

Required labels must prominently display "Gene Structure- or Function-Modifying Product" along with all potential risks, side effects, adverse effects, and possible effects on users or those who come into contact with users

First offense violations constitute a misdemeanor punishable by up to $10,000 fine or 1 year imprisonment; subsequent offenses carry up to $25,000 fine or 3 years imprisonment

Civil penalties of up to $5,000 per violation may be imposed through District Court, and courts may issue injunctions to stop ongoing violations

Effective date: October 1, 2026